Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04175678 · ClinicalTrials.gov registry record · NA

Project 1: Diet and Exercise Modulate the Sperm Epigenome in Men

A NA study of Obese and Healthy Lifestyle, sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center.

Active
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT04175678: Active NA study of Obese and Healthy Lifestyle, sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center.

NCT04175678 is a NA study of Obese and Healthy Lifestyle that is active but no longer recruiting, run by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center. The registered enrollment target is 100 participants, below the 208-participant average among 27 other Obese trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04175678, a NA study of Obese and Healthy Lifestyle, is active but no longer recruiting, sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

This is a rigorous, controlled clinical trial designed to show that diet, exercise training, and their combination in overweight, inactive men will alter epigenetic programming to create a "healthy" sperm epigenome. Our central hypotheses are: i) overweight and inactive lifestyle results in epimutations in the sperm epigenome relative to the normal epigenetic programming in lean and active men and ii) diet and exercise modulation leads to reversal of these epimutations resulting in both a healthier "phenotype" and "epigenotype" which may persist after stopping the interventions. The study is divided into three parts: 1. We will recruit 20 healthy, active men and 20 obese and inactive Hispanic men between 18 and 40 years to determine the differences in sperm epigenome (DNA methylation, histone modifications and non-coding RNAs) in a cross-sectional study in obese inactive vs. healthy active Hispanic men. Only Hispanic men will be studied because of the high prevalence of obesity and inactivity in Hispanic younger men and to reduce the genetic variability influencing the epigenome. 2. 80 obese and inactive men will be randomized to 4 groups of 20 men: 1) No intervention (control); 2) Low fat, low caloric diet; 3) Supervised, periodized endurance and resistance training without modification of diet; and 4) Both exercise and diet modification to characterize the plasticity of the sperm epigenome in response to 12-week diet and/or exercise training interventions in obese and inactive Hispanic men. Sperm epimutations will be compared before and after intervention within each group and between groups. 3. The sperm epigenome studies in 80 men randomized to no intervention or diet and/or exercise training will be repeated at 12 and 36 weeks after cessation of interventions to Identify the persistent effects of diet and exercise training on the sperm epigenome after stopping the interventions.

Primary Outcome

The Primary endpoint is to compare alterations in the sperm epigenome (DNA methylation, histone modifications, non-coding RNAs) in obese, physically inactive men before and following diet modulation and/or exercise training; this will be contrasted to a parallel no intervention group.

Interventions

  • OTHER Exercise
  • OTHER Standard care
  • OTHER Diet

Study Locations (1)

California

  • The Lundquist Institute - Torrance

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2020-02-21
Est. Completion 2026-06-30
Phase NA

What the registry record for NCT04175678 still lists

NCT04175678 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 208-participant average among 27 other Obese trials with a reported enrollment target (52% lower).

The record links to 3 conditions, with Obese appearing as the primary indexed condition, and to 3 interventions - of which Exercise is the first listed.

NCT04175678 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT04175678 about?

NCT04175678 is a clinical study titled "Project 1: Diet and Exercise Modulate the Sperm Epigenome in Men". This is a rigorous, controlled clinical trial designed to show that diet, exercise training, and their combination in overweight, inactive men will alter epigenetic programming to create a "healthy" sperm epigenome. Our central hypotheses are: i) overweight and inactive lifestyle results in epimutat...

What is the current status of trial NCT04175678?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2020-02-21. Estimated completion is 2026-06-30.

What conditions does trial NCT04175678 study?

This clinical trial studies the following conditions: Obese, Healthy Lifestyle, Men.

What interventions are being tested in trial NCT04175678?

The interventions under investigation include: Exercise (OTHER), Standard care (OTHER), Diet (OTHER).

Who is sponsoring clinical trial NCT04175678?

This trial is sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04175678 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obese

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04175678's enrollment target sits among peer trials

100 14th of 27 higher than 12 of 27 other Obese trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obese trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04175678, the US trial registry maintained by the National Library of Medicine. NCT04175678 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.